| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | 5974 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | 11923 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | 13928 | Peak area | HGD | No |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | 33320 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | Peak area | HGD & PDA | yes | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | Peak area | HGD & PDA | Yes | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | Peak area | LGD | No | |
| Reversed phase NEGATIVE ION MODE | 4-HYDROXYBENZOIC ACID (M-H)- | Peak area | N/A | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|